» Articles » PMID: 32584071

Failure to Stop Autocorrect Errors in Reading Aloud Increases in Aging Especially with a Positive Biomarker for Alzheimer's Disease

Overview
Journal Psychol Aging
Specialty Geriatrics
Date 2020 Jun 26
PMID 32584071
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The present study examined the effects of aging and CSF biomarkers of Alzheimer's disease (AD) on the ability to control production of unexpected words in connected speech elicited by reading aloud. Fifty-two cognitively healthy participants aged 66-86 read aloud 6 paragraphs with 10 malapropisms including 5 on content words (e.g., "window cartons" that elicited autocorrect errors to "window curtains") and 5 on function words (e.g., "thus concept" that elicited autocorrections to "this concept") and completed a battery of neuropsychological tests including a standardized Stroop task. Reading aloud elicited more autocorrect errors on function than content words, but these were equally correlated with age and Aβ1-42 levels. The ability to stop autocorrect errors declined in aging and with lower (more AD-like) levels of Aβ1-42, and multiplicatively so, such that autocorrect errors were highest in the oldest-old with the lowest Aβ1-42 levels. Critically, aging effects were significant even when controlling statistically for Aβ1-42. Finally, both autocorrect and Stroop errors were correlated with Aβ1-42, but only autocorrect errors captured unique variance in predicting Aβ1-42 levels. Reading aloud requires simultaneous planning and monitoring of upcoming speech. These results suggest that healthy aging leads to decline in the ability to intermittently monitor for and detect conflict during speech planning and that subtle cognitive changes in preclinical AD magnify this aging deficit. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Citing Articles

Estimating the rate of failure to notice function word errors in natural reading.

Staub A, Chen A, Peck E, Taylor N Psychon Bull Rev. 2024; .

PMID: 39349743 DOI: 10.3758/s13423-024-02586-1.


Remote data collection speech analysis in people at risk for Alzheimer's disease dementia: usability and acceptability results.

Gregory S, Harrison J, Herrmann J, Hunter M, Jenkins N, Konig A Front Dement. 2024; 2:1271156.

PMID: 39081993 PMC: 11285540. DOI: 10.3389/frdem.2023.1271156.


Language switching and speaking a nondominant language challenge executive control: Preliminary data for novel behavioral markers of Alzheimer's risk in Spanish-English bilinguals.

Garcia D, Gollan T Neuropsychology. 2024; 38(4):322-336.

PMID: 38330361 PMC: 11035100. DOI: 10.1037/neu0000943.


Autocorrection if→of function words in reading aloud: A novel marker of Alzheimer's risk.

Gollan T, Stasenko A, Li C, Smirnov D, Galasko D, Salmon D Neuropsychology. 2022; 37(7):813-826.

PMID: 35925735 PMC: 9898462. DOI: 10.1037/neu0000829.


Remote data collection speech analysis and prediction of the identification of Alzheimer's disease biomarkers in people at risk for Alzheimer's disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol.

Gregory S, Linz N, Konig A, Langel K, Pullen H, Luz S BMJ Open. 2022; 12(3):e052250.

PMID: 35292490 PMC: 8928245. DOI: 10.1136/bmjopen-2021-052250.


References
1.
Levelt W, Roelofs A, Meyer A . A theory of lexical access in speech production. Behav Brain Sci. 2001; 22(1):1-38; discussion 38-75. DOI: 10.1017/s0140525x99001776. View

2.
Woods S, Delis D, Scott J, Kramer J, Holdnack J . The California Verbal Learning Test--second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch Clin Neuropsychol. 2006; 21(5):413-20. DOI: 10.1016/j.acn.2006.06.002. View

3.
Perrin R, Fagan A, Holtzman D . Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature. 2009; 461(7266):916-22. PMC: 2810658. DOI: 10.1038/nature08538. View

4.
Lleo A, Alcolea D, Martinez-Lage P, Scheltens P, Parnetti L, Poirier J . Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study. Alzheimers Dement. 2019; 15(6):742-753. DOI: 10.1016/j.jalz.2019.01.015. View

5.
Sutphen C, Jasielec M, Shah A, Macy E, Xiong C, Vlassenko A . Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age. JAMA Neurol. 2015; 72(9):1029-42. PMC: 4570860. DOI: 10.1001/jamaneurol.2015.1285. View